Your session is about to expire
← Back to Search
Exercise Training for Breast Cancer Survivors
N/A
Waitlist Available
Led By Demetra Christou, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female based on biological sex
Diagnosis of primary invasive non-metastatic breast cancer, stages I-III
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the 12 weeks of supervised exercise training
Awards & highlights
Study Summary
This trial may help reduce risk of heart disease for 3.8 million US breast cancer survivors through a novel exercise intervention. #CVD #breastcancer
Who is the study for?
This trial is for female breast cancer survivors, aged 40-80, who've completed chemotherapy for primary invasive non-metastatic breast cancer (stages I-III) 6-18 months prior. They must be cleared by a clinician and not engage in regular intense exercise. Excluded are those with severe obesity, ongoing radiation or surgery plans, recent other treatments or interventions that could affect results, and certain cardiovascular conditions.Check my eligibility
What is being tested?
The study tests the impact of a novel exercise program on heart health in breast cancer survivors post-chemotherapy. It aims to reduce cardiovascular disease risks through tailored cardiovascular rehabilitation exercises.See study design
What are the potential side effects?
Since this trial involves an exercise program designed for rehabilitation purposes, potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue but should generally be minimal.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am biologically female.
Select...
My breast cancer is in stages I-III and has not spread to distant parts of the body.
Select...
I am between 40 and 80 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ throughout the 12 weeks of supervised exercise training
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the 12 weeks of supervised exercise training
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
% completed vs. planned exercise duration
% completed vs. planned exercise frequency
% completed vs. planned exercise intensity
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Indoor RowingExperimental Treatment1 Intervention
Research participants will be instructed how to use a Concept 2 RowErg and will be provided instruction on basic rowing skills for beginners. Exercise training will gradually progress to 50 min of moderate-intensity exercise, on 3 days per week, for 12 weeks.
Group II: Usual CareActive Control1 Intervention
Research participants in this group will have the opportunity to complete the supervised indoor rowing program after completing their post-intervention assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise training
2019
Completed Phase 1
~1110
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,633 Total Patients Enrolled
14 Trials studying Breast Cancer
591 Patients Enrolled for Breast Cancer
Demetra Christou, PhDPrincipal InvestigatorUniversity of Florida
7 Previous Clinical Trials
377 Total Patients Enrolled
2 Trials studying Breast Cancer
226 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am biologically female.My breast cancer is in stages I-III and has not spread to distant parts of the body.I finished my cancer treatment, like chemo or surgery, within the last 6 months.I am between 40 and 80 years old.You weigh a lot for your height.I am currently undergoing or will undergo radiation therapy during the study.You have been consistently doing at least 150 minutes per week of moderate exercise in the past 6 months.I am scheduled for surgery during the study.I finished my chemotherapy between 6 and 18 months ago.I am receiving or will receive cancer treatment other than ovarian suppression.I have a history of significant heart problems.My lymphedema is moderate to severe.
Research Study Groups:
This trial has the following groups:- Group 1: Indoor Rowing
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an eligibility criteria for participants in this trial?
"To be enrolled in the clinical trial, potential participants must have been diagnosed with breast cancer and must fall within a certain age range (40-80). The study is recruiting 72 volunteers."
Answered by AI
Does this trial permit elderly people to participate?
"The age range for participants in this clinical trial is between 40 and 80 years old, as delineated by the eligibility criteria."
Answered by AI
Are any new participants currently being accepted into this scientific experiment?
"According to the records on clinicaltrials.gov, this trial is not currently recruiting patients - although it was initially posted in May of 2023 and subsequently updated almost a month ago. Fortunately, there are 2,345 other medical trials that presently need volunteers."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger